Skip to content
Open Data Finder

Search results for pharmaceuticals

FiltersOpen Government Canada

132 datasets for “pharmaceuticals”

  1. Open Government Canada

    Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance: Q10: Pharmaceutical Quality System

    Health Canada | Santé CanadaUpdated 2 Nov 2023

    Q10: Pharmaceutical Quality System. This guidance has been developed by the appropriate ICH Expert Working Group and has …

    • HTML
  2. Open Government Canada

    Service Standards for Drug Submission Evaluations (Pharmaceuticals and Biologic Products) under the Food and Drug Regulations - Health Canada

    Health Canada | Santé CanadaUpdated 3 Sept 2023

    Service Delivery Standards.

    • HTML
  3. Open Government Canada

    Guidance document on the application for a certificate of a pharmaceutical product and good manufacturing practice certificate (GUI-0024)

    Health Canada | Santé CanadaUpdated 29 Dec 2021

    This document clarifies the requirements to be met for the issuance of a Certificate of a Pharmaceutical Product …

    • HTML
  4. Open Government Canada

    Notice of publication: Good manufacturing practices guidelines for active pharmaceutical ingredients

    Health Canada | Santé CanadaUpdated 27 Feb 2023

    On February 10, 2022, the Health Product Compliance Directorate posted Good manufacturing practices guidelines for active pharmaceutical ingredients …

    • HTML
  5. Open Government Canada

    Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines Regime

    Health Canada | Santé CanadaUpdated 17 Sept 2020

    The pharmaceutical company must complete and submit to the Commissioner of Patents one of the forms listed below …

    • HTML
  6. Open Government Canada

    Good manufacturing practices guidelines for active pharmaceutical ingredients (GUI-0104) - Summary

    Health Canada | Santé CanadaUpdated 27 Feb 2023

    This guide is for people who work with Active Pharmaceutical Ingredients (APIs) and their intermediates to understand and …

    • HTML
  7. Open Government Canada

    Guidance Document - Quality (Chemistry and Manufacturing) Guidance: Clinical Trial Applications (CTAs) for Pharmaceuticals

    Health Canada | Santé CanadaUpdated 2 Jun 2021

    To assist submission sponsors in preparing Clinical Trial Applications (CTAs) filed with Health Canada by outlining the Quality …

    • HTML
  8. Open Government Canada

    Guidance Document - Pharmaceutical Development ICH Topic Q8(R2)

    Health Canada | Santé CanadaUpdated 2 Dec 2023

    This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation …

    • HTML
  9. Open Government Canada

    Safety Pharmacology Studies for Human Pharmaceuticals ICH Topic S7A

    Health Canada | Santé CanadaUpdated 2 Dec 2023

    This guidance has been developed by the appropriate ICH Expert Working Group and has been subject to consultation …

    • HTML
  10. Open Government Canada

    Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance Document: Q9: Quality Risk Management

    Health Canada | Santé CanadaUpdated 1 Nov 2023

    Q9: Quality Risk Management. This guidance has been developed by the appropriate ICH Expert Working Group and has …

    • HTML
  11. Open Government Canada

    Adoption of International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH) Guidance

    Health Canada | Santé CanadaUpdated 1 Nov 2023

    Q8, Q9 and Q10 Questions & Answers (R4). This guidance has been developed by the appropriate ICH Expert Working …

    • HTML
  12. Open Government Canada

    M3(R2): Guidance on Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals

    Health Canada | Santé CanadaUpdated 2 Dec 2023

    … to support human clinical trials of a given scope and duration as well as marketing authorization for pharmaceuticals.

    • HTML
  13. Open Government Canada

    Guidance Document: Labelling of Pharmaceutical Drugs for Human Use

    Health Canada | Santé CanadaUpdated 7 Jul 2021

    The purpose of this document is to provide guidance to sponsors to facilitate compliance with the labelling requirements …

    • HTML
  14. Open Government Canada

    Toxicity of the pharmaceuticals finasteride and melengestrol acetate to the mayfly Hexagenia spp.

    Environment and Climate Change Canada | Environnement et Changement climatique CanadaUpdated 16 May 2023

    The toxicity of pharmaceuticals finasteride (FIN) and melengestrol acetate (MGA) was assessed in chronic (42 days) sediment tests …

    • HTML
  15. Open Government Canada

    Draft Guidance for Industry: Quality Guidance: Applications for Drug Identification Numbers (DINAs) for Pharmaceuticals

    Health Canada | Santé CanadaUpdated 3 Sept 2023

    This document is intended to provide guidance with respect to the Quality (Chemistry and Manufacturing) portion of Applications …

    • HTML
  16. Open Government Canada

    Toxicity of the pharmaceuticals finasteride and melengestrol acetate to the amphipod Hyalella azteca

    Environment and Climate Change Canada | Environnement et Changement climatique CanadaUpdated 24 Jan 2022

    The toxicity of pharmaceuticals finasteride (FIN) and melengestrol acetate (MGA) was assessed in chronic (42 days) sediment tests …

    • HTML
  17. Open Government Canada

    Updated: Notice - Notification of Safety Labelling Changes to the Product Monographs of Pharmaceutical Drug Products

    Health Canada | Santé CanadaUpdated 29 Dec 2021

    … new safety information in PMs of brand name pharmaceutical drug products (those regulated under Division 8 of the …

    • HTML
  18. Open Government Canada

    Guidance Document - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Impurities in New Drug Substances - ICH Topic Q3A(R2)

    Health Canada | Santé CanadaUpdated 2 Dec 2023

    This document is intended to provide guidance for registration applications on the content and qualification of impurities in …

    • HTML
  19. Open Government Canada

    Guidance Document: Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only)

    Health Canada | Santé CanadaUpdated 7 Jul 2021

    … These new drugs may include pharmaceuticals, biologics, and radiopharmaceuticals for human use, including those submissions for which a …

    • HTML
  20. Open Government Canada

    Notice: Health Canada and United States Food and Drug Administration Joint Public Consultation on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guidelines

    Health Canada | Santé CanadaUpdated 29 Dec 2021

    … International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines currently under development. The …

    • HTML
“pharmaceuticals” datasets · Open Data Finder